Literature DB >> 2311584

Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12.

T Braun1, E Bober, B Winter, N Rosenthal, H H Arnold.   

Abstract

The Myf-6 gene, a novel member of the human gene family of muscle determination factors has been detected by its highly conserved sequence coding for a putative helix-loop-helix domain. This sequence motif is a common feature of all Myf factors and other regulatory proteins. The new Myf gene is located on human chromosome 12, approximately 6.5 Kb upstream of the Myf-5 locus in a closely linked cluster of myogenic determination genes. Myf-6 cDNAs were isolated from human and mouse skeletal muscle, the only tissue in which expression of the corresponding mRNA was observed. In contrast to human primary muscle cell cultures which express moderate levels of Myf-6 mRNA, most established rodent muscle cell lines completely lack this mRNA. Myogenic 10T1/2 cells, however, induced by the expression of either pEMSV-Myf-4 or pEMSV-Myf-5 activate their endogenous mouse Myf-6 gene. Constitutive expression of Myf-6 cDNA in C3H 10T1/2 fibroblasts establishes the muscle phenotype at a similar frequency to the previously characterized myogenic factors. Moreover, muscle-specific CAT reporter constructs containing either the human myosin light chain (MLC) enhancer or the promoter of the embryonic myosin light chain gene are activated in NIH 3T3 fibroblasts or in CV1 kidney cells by cotransfection of Myf-6 expression vehicles. This transcriptional activation occurs in the absence of any apparent conversion of the cellular phenotype of the recipient cells. Glutathione-S-transferase fusion proteins with Myf-3, Myf-4 or Myf-5 specifically bind to a MEF-like consensus sequence present in the human MLC enhancer and the MLC1 emb promoter. In contrast, the Myf-6 hybrid protein interacts weakly with the same sequences showing lower affinity and reduced specificity. Since co-expressed pEMSV-Myf-6, nevertheless, is able to activate transcription of the MLC-CAT reporter constructs in non-muscle tissue culture cells, the different DNA binding properties in vitro might suggest that transactivation of gene expression by Myf-6 involves distinct binding sites and/or additional protein factors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2311584      PMCID: PMC551742          DOI: 10.1002/j.1460-2075.1990.tb08179.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine.

Authors:  S M Taylor; P A Jones
Journal:  Cell       Date:  1979-08       Impact factor: 41.582

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle.

Authors:  D Yaffe; O Saxel
Journal:  Nature       Date:  1977 Dec 22-29       Impact factor: 49.962

4.  A myogenic cell line with altered serum requirements for differentiation.

Authors:  D Yaffe; O Saxel
Journal:  Differentiation       Date:  1977       Impact factor: 3.880

5.  Unidirectional digestion with exonuclease III creates targeted breakpoints for DNA sequencing.

Authors:  S Henikoff
Journal:  Gene       Date:  1984-06       Impact factor: 3.688

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA.

Authors:  C Auffray; F Rougeon
Journal:  Eur J Biochem       Date:  1980-06

8.  5-Azacytidine induction of stable mesodermal stem cell lineages from 10T1/2 cells: evidence for regulatory genes controlling determination.

Authors:  S F Konieczny; C P Emerson
Journal:  Cell       Date:  1984-10       Impact factor: 41.582

9.  Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products.

Authors:  T Braun; E Bober; G Buschhausen-Denker; S Kohtz; K H Grzeschik; H H Arnold; S Kotz
Journal:  EMBO J       Date:  1989-12-01       Impact factor: 11.598

10.  Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro.

Authors:  D Bader; T Masaki; D A Fischman
Journal:  J Cell Biol       Date:  1982-12       Impact factor: 10.539

View more
  131 in total

1.  The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs.

Authors:  T H Christensen; L Kedes
Journal:  Gene Expr       Date:  1999

2.  A novel myoblast enhancer element mediates MyoD transcription.

Authors:  S J Tapscott; A B Lassar; H Weintraub
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

3.  Different E-box regulatory sequences are functionally distinct when placed within the context of the troponin I enhancer.

Authors:  K E Yutzey; S F Konieczny
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

4.  A single MEF-2 site is a major positive regulatory element required for transcription of the muscle-specific subunit of the human phosphoglycerate mutase gene in skeletal and cardiac muscle cells.

Authors:  Y Nakatsuji; K Hidaka; S Tsujino; Y Yamamoto; T Mukai; T Yanagihara; T Kishimoto; S Sakoda
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

5.  The MRF4 activation domain is required to induce muscle-specific gene expression.

Authors:  K L Mak; R Q To; Y Kong; S F Konieczny
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

6.  Tissue-specific expression of the skeletal alpha-actin gene involves sequences that can function independently of MyoD and Id.

Authors:  G E Muscat; J Emery; E S Collie
Journal:  Gene Expr       Date:  1992

7.  HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors.

Authors:  J S Hu; E N Olson; R E Kingston
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

8.  The 5'-flanking region of the mouse muscle nicotinic acetylcholine receptor beta subunit gene promotes expression in cultured muscle cells and is activated by MRF4, myogenin and myoD.

Authors:  C A Prody; J P Merlie
Journal:  Nucleic Acids Res       Date:  1992-05-11       Impact factor: 16.971

9.  A ubiquitous factor (HF-1a) and a distinct muscle factor (HF-1b/MEF-2) form an E-box-independent pathway for cardiac muscle gene expression.

Authors:  S Navankasattusas; H Zhu; A V Garcia; S M Evans; K R Chien
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

Review 10.  Building muscle: molecular regulation of myogenesis.

Authors:  C Florian Bentzinger; Yu Xin Wang; Michael A Rudnicki
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.